| Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination | NPJ Vaccines |  | | 2020 | 487 | 150 |
|
| A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner | Frontiers in immunology | | | 2020 | 288 | 177 |
|
| Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centers | Cell Reports | | | 2019 | 337 | 465 |
|
| Site-specific DC surface signatures influence CD4+ T cell co-stimulation and lung-homing | Frontiers in Immunology | | | 2019 | 301 | 371 |
|
| Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation | Frontiers in Immunology | | | 2019 | 286 | 408 |
|
| Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlan | Frontiers in Immunology | | | 2018 | 507 | 821 |
|
| Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report | The New England journal of medicine | | | 2016 | 945 | 318 |
|
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial | Lancet. Infectious diseases |  | | 2015 | 717 | 0 |
|
| MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life | The Journal of immunology | | | 2015 | 688 | 2 |
|
| Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of concept | Vaccine | | | 2015 | 631 | 257 |
|
| Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants | The Journal of immunology | | | 2012 | 618 | 0 |
|
